Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Now it will probably go up steadily, but I think a lot of good results will be coming up. 2015 is even better IMO because that's when a lot of early results will be seen for ophthalmology.

Here are some Catalysts to watch for in 2015:

1. More 3-month results from hypertrophic scars early 2015
2. keloid 1-month and 3-month results early 2015
3. Early results from other hypertrophic scar study
4. IND for RXI-109 in PVR and other eye diseases
5. pre-clinical results from mac degeneration, retinoblastoma, etc.
6. Finally last but not least the adding of an additional phase 2 product to pipeline. I'm still not clear what this means but it is coming for 2015 and I don't see how the company would have money to acquire phase 2 ready product. I think it is some type of partnership/collaboration IMO.